Literature DB >> 17584296

Identification, developmental expression and regulation of the Xenopus ortholog of human FANCG/XRCC9.

Stacie Stone1, Alexandra Sobeck, Margriet van Kogelenberg, Bendert de Graaf, Hans Joenje, Jan Christian, Maureen E Hoatlin.   

Abstract

Fanconi anemia (FA) is associated with variable developmental abnormalities, bone marrow failure and cancer susceptibility. FANCG/XRCC9 is member of the FA core complex, a group of proteins that control the monoubiquitylation of FANCD2, an event that plays a critical role in maintaining genomic stability. Here we report the identification of the Xenopus laevis ortholog of human FANCG (xFANCG), its expression during development, and its molecular interactions with a partner protein, xFANCA. The xFANCG protein sequence is 47% similar to its human ortholog, with highest conservation in the two putative N-terminal leucine zippers and the tetratricopeptide repeat (TPR) motifs. xFANCG is maternally and zygotically transcribed. Prior to the midblastula stage, a single xFANCG transcript is observed but two additional alternatively spliced mRNAs are detected after the midblastula transition. One of the variants is predicted to encode a novel isoform of xFANCG lacking exon 2. The mutual association between FANCG and FANCA required for their nuclear import is conserved in Xenopus egg extracts. Our data demonstrate that interactions between FANCA and FANCG occur at the earliest stage of vertebrate development and raise the possibility that functionally different isoforms of xFANCG may play a role in early development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584296     DOI: 10.1111/j.1365-2443.2007.01096.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  5 in total

1.  Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.

Authors:  James B Wilson; Eric Blom; Ryan Cunningham; Yuxuan Xiao; Gary M Kupfer; Nigel J Jones
Journal:  Mutat Res       Date:  2010-05-05       Impact factor: 2.433

2.  FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures.

Authors:  Fenghua Yuan; Jimmy El Hokayem; Wen Zhou; Yanbin Zhang
Journal:  J Biol Chem       Date:  2009-06-27       Impact factor: 5.157

3.  Fanconi anemia proteins stabilize replication forks.

Authors:  Lily Chien Wang; Stacie Stone; Maureen Elizabeth Hoatlin; Jean Gautier
Journal:  DNA Repair (Amst)       Date:  2008-09-25

4.  Fanconi anemia proteins FANCD2 and FANCI exhibit different DNA damage responses during S-phase.

Authors:  Archana Sareen; Indrajit Chaudhury; Nicole Adams; Alexandra Sobeck
Journal:  Nucleic Acids Res       Date:  2012-06-29       Impact factor: 16.971

Review 5.  Xenbase: Facilitating the Use of Xenopus to Model Human Disease.

Authors:  Mardi J Nenni; Malcolm E Fisher; Christina James-Zorn; Troy J Pells; Virgilio Ponferrada; Stanley Chu; Joshua D Fortriede; Kevin A Burns; Ying Wang; Vaneet S Lotay; Dong Zhou Wang; Erik Segerdell; Praneet Chaturvedi; Kamran Karimi; Peter D Vize; Aaron M Zorn
Journal:  Front Physiol       Date:  2019-02-26       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.